Oligonucleotide Manufacturing Facilities
DPS Group Global DPS Group Global
150 subscribers
1,757 views
0

 Published On May 10, 2022

Molecular-targeted agents employing chemically synthesized oligonucleotides for patient therapeutics are an emerging market experiencing rapid growth and development worldwide. Learn how we can support your next oligonucleotide project: https://www.dpsgroupglobal.com/oligon...

show more

Share/Embed